Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

New CFO Jordison steps up

Sygnature has appointed Louisa Jordison as Chief Financial Officer.

We’re aiming to build on our success after growing from 200 to 450 employees in under four years.

Louisa joined us in 2019 as Director of Strategic Planning, and enters the boardroom having previously spent more than a decade in Deloitte’s corporate finance advisory team and worked as Senior Strategic Planning Manager at Experian.

She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature.

Dr Simon Hirst, CEO and founder of Sygnature Discovery, said: “Louisa has an incredibly strong finance background and will bring a wealth of experience to the role of CFO.

“Louisa’s appointment comes at an exciting time for our business as we develop relationships with customers new and old in our key US, UK, European and Asian markets.

Louisa Jordison, Chief Financial Officer at Sygnature Discovery, said: “I am looking forward to working with the board, my team and all colleagues in my new capacity.

“This is a fantastic place to work and home to real scientific innovation, so there are plenty of brilliant opportunities ahead of us.”

Earlier this year, Sygnature opened an office in South San Francisco and hired Dr David Lustig as Vice President of Business Development for North America to spearhead its expansion across the Atlantic.

Also in 2021, we received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co – with the exiting shareholder, Phoenix Equity Partners, having seen our revenue more than double since September 2017.

Simon added: “This has truly been a tremendous period for Sygnature.

“As we look to 2022 and beyond, the future looks very bright indeed.”

Latest News

View All

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

Sygnature Discovery acquires Peak Proteins

Paper on drug discovery equipment

500 – and counting!

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.